I’m in the US, and I pushed through the side effects and didn’t go up in dose as long as I was losing weight (not diabetic). Never went higher than 5.0 Zepbound. Now, I’m at goal. I think the patient has to be determined to push through and stay the course. Aka, sometimes, you just have to suck it up!!!!
Blue Cross study done in US context with $1000 price tag. I am wondering if lower UK prices (thanks to NHS negotiated low prices) made a difference in retention. Any UK study?
I’m in the US, and I pushed through the side effects and didn’t go up in dose as long as I was losing weight (not diabetic). Never went higher than 5.0 Zepbound. Now, I’m at goal. I think the patient has to be determined to push through and stay the course. Aka, sometimes, you just have to suck it up!!!!
Blue Cross study done in US context with $1000 price tag. I am wondering if lower UK prices (thanks to NHS negotiated low prices) made a difference in retention. Any UK study?
Good question, not yet a public one but would be very interesting to compare. My instinct is that they’re quite similar.